Cookie Policy - To find out more about cookies on this website, see our privacy policy

Cookie Policy

We Help Companies Find New Sales Opportunities

We Help Companies Find New Sales Opportunities

Bioglan Pharma

Bioglan is selling its GenPlus generics telesales business in Waterlooville to Ethercorp for a nominal sum, in order to focus on dermatology and the development of the Biosphere drug delivery system.

Bioglan is planning to buy or set up new companies in Italy and Spain later this year, as part of a strategy to expand its speciality pharmaceuticals business across Europe.

Bioglan Pharma has acquired the remaining 50% of CS Laboratories, the French pharmaceutical company, and is now looking to further expand its activities in the US and Europe.